Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

about

Abscisic Acid: A Novel Nutraceutical for Glycemic Control.Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection.Solving Immunology?Abscisic Acid as Pathogen Effector and Immune Regulator

P2860

Q33790397-47527174-2A83-4BDD-8401-D1717C4B8749 Q37653825-38637E17-0343-44FA-9D47-634A209309E7 Q39041736-08DD89E8-31A3-4B6E-AA49-4B871B061ADA Q39281992-DF68F0BE-1E85-4AFE-847A-74D526A74509

P2860

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

Item

http://www.wikidata.org/entity/Q41159285

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

@en

type

Item

label

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

@en

prefLabel

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

@en

P1476

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

@en

P2093

Bernard S Jortner

http://www.w3.org/2001/XMLSchema#string

Geraldine Magnin-Bissel

http://www.w3.org/2001/XMLSchema#string

Jonathan Hinckley

http://www.w3.org/2001/XMLSchema#string

Katie Boes

http://www.w3.org/2001/XMLSchema#string

Marion Ehrich

http://www.w3.org/2001/XMLSchema#string

Noah Philipson

http://www.w3.org/2001/XMLSchema#string

Philippe Bissel

http://www.w3.org/2001/XMLSchema#string

Richard D Gandour

http://www.w3.org/2001/XMLSchema#string

Stephen R Werre

http://www.w3.org/2001/XMLSchema#string

P2860

Abscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gamma

Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.

Lanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes.

GI clinical research 2002-2003: the year in review.

When poor solubility becomes an issue: from early stage to proof of concept.

International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.

P304

521-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1091581816646356

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Josep Bassaganya-Riera

Raquel Hontecillas

Adria Carbo

Casandra W. Philipson

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27230993

http://www.w3.org/2001/XMLSchema#string

P932

5033715

http://www.w3.org/2001/XMLSchema#string

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

about

P2860

P2860

Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932